Abstract:Ethnopharmacological relevance: Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver-related morbidity and mortality, with hepatic steatosis being the hallmark symptom. Salvia miltiorrhiza Bunge (Smil, Dan-Shen) and Ligusticum striatum DC (Lstr, Chuan-Xiong) are commonly used to treat cardiovascular diseases and have the potential to regulate lipid metabolism. However, whether Smil/Lstr combo can be used to treat NAFLD and the mechanisms underlying its lipid-regulating properties remain unclear. Purpose: To assess the feasibility and reliability of a short-term high-fat diet (HFD) induced zebrafish model for evaluating hepatic steatosis phenotype and to investigate the liver lipid-lowering effects of Smil/Lstr, as well as its active components. Methods: The phenotypic alterations of liver and multiple other organ systems were examined in the HFD zebrafish model using fluorescence imaging and histochemistry. The liver-specific lipid-lowering effects of Smil/Lstr combo were evaluated endogenously. The active molecules and functional mechanisms were further explored in zebrafish, human hepatocytes, and hamster models. Results: In 5-day HFD zebrafish, significant lipid accumulation was detected in the blood vessels and the liver, as evidenced by increased staining with Oil Red O and fluorescent lipid probes. Hepatic hypertrophy was observed in the model, along with macrovesicular steatosis. Smil/Lstr combo administration effectively restored the lipid profile and alleviated hepatic hypertrophy in the HFD zebrafish. In oleic-acid stimulated hepatocytes, Smil/Lstr combo markedly reduced lipid accumulation and cell damage. Subsequently, based on zebrafish phenotypic screening, the natural phthalide senkyunolide I (SEI) was identified as a major molecule mediating the lipid-lowering activities of Smil/Lstr combo in the liver. Moreover, SEI upregulated the expression of the lipid metabolism regulator PPARα and downregulated fatty acid translocase CD36, while a PPARα antagonist sufficiently blocked the regulatory effect of SEI on hepatic steatosis. Finally, the roles of SEI on hepatic lipid accumulation and PPARα signaling were further verified in the hamster model. Conclusions: We proposed a zebrafish-based screening strategy for modulators of hepatic steatosis and discovered the regulatory roles of Smil/Lstr combo and its component SEI on liver lipid accumulation and PPARα signaling, suggesting their potential value as novel candidates for NAFLD treatment.

[Lipid-Lowering Effect of Seven Traditional Chinese Medicine Monomers in Zebrafish System].

Application of chrysophanol in zebrafish to reduce dietary introduced lipid and its possible mechanism.

Rapid analysis of hypolipidemic drugs in a live zebrafish assay

Efficient and rapid liquid reduction animal model

Model Design for Screening Effective Antihyperlipidemic Drugs Using Zebrafish System.

Optimizing Methods for the Study of Intravascular Lipid Metabolism in Zebrafish

β-Sitosterol Reduces the Content of Triglyceride and Cholesterol in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Zebrafish (Danio rerio) Model

Effect of Emodin on Hyperlipidemia and Hepatic Lipid Metabolism in Zebrafish Larvae Fed a High-Cholesterol Diet

Glycerol Monolaurate and Triglycerol Monolaurate Alleviated High-Fat Diet Induced Lipid Accumulation and Damage of Liver in Zebrafish (danio Rerio)

Hypolipidemic Effect of Rice Bran Oil Extract Tocotrienol in High-Fat Diet-Induced Hyperlipidemia Zebrafish (Danio Rerio) Induced by High-Fat Diet

High Fat Plus High Cholesterol Diet Lead to Hepatic Steatosis in Zebrafish Larvae: a Novel Model for Screening Anti-Hepatic Steatosis Drugs

Nonalcoholic Fatty Liver Disease Development In Zebrafish Upon Exposure To Bis(2-Ethylhexyl)-2,3,4,5-Tetrabromophthalate, A Novel Brominated Flame Retardant

A high-cholesterol zebrafish diet promotes hypercholesterolemia and fasting-associated liver steatosis

Identification of Key Hypolipidemic Components and Exploration of the Potential Mechanism of Total Flavonoids from Rosa sterilis Based on Network Pharmacology, Molecular Docking, and Zebrafish Experiment

Systemic Effect of Dietary Lipid Levels and Α-Lipoic Acid Supplementation on Nutritional Metabolism in Zebrafish ( Danio Rerio ): Focusing on the Transcriptional Level

Danggui Shaoyao San ameliorates the lipid metabolism via the PPAR signaling pathway in a Danio rerio (zebrafish) model of hyperlipidemia

Chlorogenic acid and its isomers attenuate NAFLD by mitigating lipid accumulation in oleic acid‐induced HepG2 cells and high‐fat diet‐ fed zebrafish

Hypolipidemic effect of polysaccharide from Sargassum fusiforme and its ultrasonic degraded polysaccharide on zebrafish fed high-fat diet

Lipid-modulate activity of Cichorium glandulosum Boiss.et Huet polysaccharide in nonalcoholic fatty liver disease larval zebrafish model.

Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPARα signaling in zebrafish and hamster models